SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: LJM8/4/2005 8:46:44 PM
  Read Replies (2) of 933
 
Kosan Biosciences to offer 4.5 million shares
Thu Aug 4, 2005 08:10 PM ET
NEW YORK, Aug 4 (Reuters) - Kosan Biosciences Inc. (KOSN.O: Quote, Profile, Research) said on Thursday it plans to offer 4.5 million common shares under an existing shelf registration statement.
Kosan said it expects underwriters will be granted an over-allotment option for 675,000 additional shares. Credit Suisse First Boston is acting as sole book-running manager of this offering, with SG Cowen & Co. and CIBC World Markets Corp. acting as co-managers, the company said in a statement
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext